Bone Biologics Corporation (BBLG)
NASDAQ: BBLG · Real-Time Price · USD
1.460
-0.010 (-0.68%)
At close: Jun 18, 2026, 4:00 PM EDT
1.390
-0.070 (-4.79%)
After-hours: Jun 18, 2026, 7:57 PM EDT
Bone Biologics Market Cap
Bone Biologics has a market cap or net worth of $2.62 million as of June 18, 2026. Its market cap has decreased by -3.22% in one year.
Market Cap
2.62M
Enterprise Value
-1.91M
1-Year Change
-3.22%
Ranking
Category
Stock Price
$1.46
Market Cap Chart
Since March 31, 2016, Bone Biologics's market cap has decreased from $155.72M to $2.62M, a decrease of -98.32%. That is a compound annual growth rate of -32.94%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 18, 2026 | 2.62M | 0.69% |
| Dec 31, 2025 | 2.60M | 12.38% |
| Dec 31, 2024 | 2.32M | -4.06% |
| Dec 29, 2023 | 2.41M | -24.75% |
| Dec 30, 2022 | 3.21M | -91.19% |
| Dec 31, 2021 | 36.43M | -58.55% |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 23, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| VivoSim Labs | 3.39M |
| GeoVax Labs | 3.38M |
| Clearmind Medicine | 3.20M |
| GRI Bio | 3.14M |
| Virax Biolabs Group | 3.13M |
| Decoy Therapeutics | 3.13M |
| Azitra | 2.98M |
| Oragenics | 2.76M |